A prime opportunity for pharma to raise its strategic game in ESG.
Jen Nixon
Advertisement
Articles by Jen Nixon
The pharma industry is beginning to perform better with environmental, social, and governance (ESG).
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pilot Targets Faster Early-Stage Drug Trial Starts
2
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts
3
The Next Evolution of Class of Trade: Why Customer Identity Is Becoming Market Access’s Hardest Problem
4
DARPA's Role in Bringing Manufacturing Back to the US
5